Company intelligence / Profile preview

3i Gestion

London, United Kingdom

Ownership: Private
Employees: ~250
Development stage: Other

Overview

3i Group is a leading international investment manager focused on mid-market private equity and infrastructure. The firm operates a dedicated healthcare investment team that targets high-growth sub-sectors, including medical technology, pharmaceutical services, and healthcare provision. 3i Gestion serves as the firm's French management entity, overseeing a diverse portfolio of investments across the region. Notable healthcare investments by the group have included companies such as Atnahs (specialty pharmaceuticals), Q Holding (medical components), and Sani-Tech West. Headquartered in London, 3i Group is a constituent of the FTSE 100 Index and maintains a significant global presence with offices across Europe and North America.

Industry: Investors

Beyond the preview

Go deeper on 3i Gestion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3i Gestion.

Explore the full profile